Company Profile

SHAIMIL LABORATORIES, ESTABLISHED IN 1986, IS A WHO-GMP-CERTIFIED PHARMACEUTICAL MANUFACTURER SPECIALIZING IN ORAL SOLID DOSAGE FORMS SUCH AS TABLETS AND CAPSULES. WITH A STRONG PRESENCE IN EUROPE, LATIN AMERICA, AFRICA, AND SOUTH ASIA, WE ARE DEDICATED TO PROVIDING HIGH-QUALITY, AFFORDABLE MEDICINES GLOBALLY. OUR EXPANDED PORTFOLIO INCLUDES INJECTABLES, HARD AND SOFT GELATIN CAPSULES, BIOSIMILARS (HEPARIN & INSULIN), SACHETS, ORAL LIQUIDS, AND TOPICALS. WE MAINTAIN OVER 150 DOSSIERS FOR TABLETS, 65+ FOR INJECTIONS, AND MANY MORE ACROSS OTHER CATEGORIES. OUR FACILITY WAS RECENTLY AUDITED BY TANZANIA AND WE ARE ACTIVELY PREPARING FOR AN UPCOMING AUDIT BY THE PHILIPPINES FDA AND ETHOPIA FDA, ENHANCING OUR COMMITMENT TO REGULATORY EXCELLENCE. SHAIMIL LABORATORIES CONTINUES TO BE A TRUSTED PARTNER IN ADVANCING GLOBAL HEALTHCARE THROUGH QUALITY, COMPLIANCE, AND INNOVATION.